Ozempic Maker ’s New Weight Loss Pill Beats Wegovy In Early Trial — What To Know About Novo Nordisk’s Amycretin

Patients taking the drug in an early stage clinical trial lost 13% of their weight over 12 weeks, Novo Nordisk told investors.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news topline Source Type: news